Published December 2017 | Version v1
Journal article

Role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography in evaluation of immunoglobulin G4-related disease

  • 1. Department of Nuclear Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh (India)

Description

Immunoglobulin G4-related disease (IgG4RD) is a multi-system disease complex with no specific etiology. The disease process is known to involve the exocrine glands, kidneys, lungs, lymph nodes, etc. Currently, role of conventional modalities in assessment of disease diagnosis, extent and severity is limited. 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) being a molecular/functional imaging technique has the potential to provide valuable information in this aspect. We retrospectively analyzed 10 previously untreated patients with clinical and biochemical suspicion of IgG4RD, who had undergone 18F-FDG PET/CT from November 1, 2016, to August 31, 2017. Analysis was done on the basis of qualitative and semi-quantitative parameters (maximum standardized uptake value (SUVmax )). Mean age of the 10 patients (M:F=1:1) was 37.1 ± 24.1 years. The most common presenting complaint was abdominal pain (5/10). Disease involvement of two or more sites was noted on 18F-FDG PET/ CT in all the patients. The disease spectrum on 18F-FDG PET/ CT included palatine tonsils (6/10, mean SUVmax 6.7), lymph nodes (5/10, SUVmax 7.1), salivary and lacrimal glands, lungs, bile ducts, kidneys, esophagus, pancreas, spleen, and retroperitoneum, in the decreasing order of frequency, which was consistent with the pattern, in literature. The maximum 18F-FDG uptake was noted in the axillary lymph nodes (SUVmax 11.9) and minimum in bile ducts (SUVmax 1.2). 18F-FDG PET/CT proved beneficial in the overall assessment of disease extent and severity in these patients and in providing a holistic picture which is not possible with the conventional diagnostic modalities. Thus, 18F-FDG PET/CT is a useful modality in the primary evaluation of patients with IgG4RD. (author)

Additional details

Publishing Information

Journal Title
Indian Journal of Nuclear Medicine
Journal Volume
32
Journal Issue
suppl
Journal Page Range
p. 12
ISSN
0972-3919

Conference

Title
49. annual conference of the society of nuclear medicine, India
Acronym
SNMI-2017
Dates
14-17 Dec 2017
Place
New Delhi (India)